EyePoint Pharmaceuticals Inc (EYPT)
Stock chart
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2024-08-21 | 2024-08-21 | B Purchase | Non-Executive Director |
5,000
+61.3%
7.95USD 39,750 |
5,000 +61.3% | 7.95 | USD 39,750 | |
| 2024-08-21 | 2024-08-20 | B Purchase | Non-Executive Director |
2,567
+34.7%
7.79USD 19,997 |
2,567 +34.7% | 7.79 | USD 19,997 | |
| 2024-08-21 | 2024-08-19 | B Purchase | Non-Executive Director |
12,500
+312.5%
7.98USD 99,750 |
12,500 +312.5% | 7.98 | USD 99,750 | |
| 2024-08-20 | 2024-08-16 | B Purchase | Non-Executive Director |
3,173
+3.4%
7.88USD 25,003 |
3,173 +3.4% | 7.88 | USD 25,003 | |
| 2024-07-16 | 2024-07-12 | S Sale | Non-Executive Director |
11,625
-86.3%
10.06USD 116,995 |
11,625 -86.3% | 10.06 | USD 116,995 | |
| 2024-06-04 | 2024-06-03 | S Sale | Non-Executive Director |
11,625
-75.9%
10.30USD 119,705 |
11,625 -75.9% | 10.30 | USD 119,705 | |
| 2024-05-16 | 2024-05-14 | S Sale | Non-Executive Director |
11,625
-67.7%
12.65USD 147,045 |
11,625 -67.7% | 12.65 | USD 147,045 | |
| 2024-05-08 | 2024-05-06 | B Purchase |
Cormorant Asset Management, LP Large shareholder |
207,153
+2.6%
12.36USD 2,560,411 |
207,153 +2.6% | 12.36 | USD 2,560,411 | |
| 2024-05-08 | 2024-05-06 | B Purchase |
Cormorant Asset Management, LP Large shareholder |
642,847
+8.6%
11.70USD 7,521,310 |
642,847 +8.6% | 11.70 | USD 7,521,310 | |
| 2024-04-22 | 2024-04-18 | B Purchase |
Cormorant Asset Management, LP Large shareholder |
186,521
+2.6%
18.90USD 3,525,247 |
186,521 +2.6% | 18.90 | USD 3,525,247 | |
| 2024-04-22 | 2024-04-18 | B Purchase |
Cormorant Asset Management, LP Large shareholder |
395,244
+5.7%
17.62USD 6,964,199 |
395,244 +5.7% | 17.62 | USD 6,964,199 | |
| 2024-02-05 | 2024-02-02 | S Sale |
SVP & Chief Commercial Officer Officer |
209
-0.5%
28.49USD 5,954 |
209 -0.5% | 28.49 | USD 5,954 | |
| 2024-01-30 | 2024-01-26 | S Sale |
Chief Medical Officer Officer |
33,665
-48.0%
25.77USD 867,672 |
33,665 -48.0% | 25.77 | USD 867,672 | |
| 2024-01-30 | 2024-01-26 | S Sale |
Chief Medical Officer Officer |
15,609
-18.2%
25.41USD 396,572 |
15,609 -18.2% | 25.41 | USD 396,572 | |
| 2024-01-30 | 2024-01-26 | S Sale |
Chief Medical Officer Officer |
51
-0.1%
25.41USD 1,296 |
51 -0.1% | 25.41 | USD 1,296 | |
| 2024-01-29 | 2024-01-26 | S Sale |
SVP & Chief Commercial Officer Officer |
9,604
-20.2%
25.27USD 242,717 |
9,604 -20.2% | 25.27 | USD 242,717 | |
| 2024-01-29 | 2024-01-26 | S Sale |
SVP & Chief Commercial Officer Officer |
16,413
-25.7%
25.45USD 417,653 |
16,413 -25.7% | 25.45 | USD 417,653 | |
| 2024-01-29 | 2024-01-25 | S Sale |
Chief Medical Officer Officer |
300
-0.8%
25.00USD 7,500 |
300 -0.8% | 25.00 | USD 7,500 | |
| 2024-01-29 | 2024-01-25 | S Sale |
Chief Medical Officer Officer |
300
-0.8%
25.00USD 7,500 |
300 -0.8% | 25.00 | USD 7,500 | |
| 2024-01-26 | 2024-01-25 | S Sale |
SVP & Chief Commercial Officer Officer |
300
-0.8%
25.00USD 7,500 |
300 -0.8% | 25.00 | USD 7,500 | |
| 2024-01-26 | 2024-01-25 | S Sale |
SVP & Chief Commercial Officer Officer |
300
-0.8%
25.00USD 7,500 |
300 -0.8% | 25.00 | USD 7,500 | |
| 2024-01-26 | 2024-01-24 | S Sale |
SVP & Chief Commercial Officer Officer |
5,600
-12.9%
25.01USD 140,068 |
5,600 -12.9% | 25.01 | USD 140,068 | |
| 2024-01-26 | 2024-01-24 | S Sale |
SVP & Chief Commercial Officer Officer |
5,700
-11.6%
25.01USD 142,554 |
5,700 -11.6% | 25.01 | USD 142,554 | |
| 2024-01-25 | 2024-01-24 | S Sale |
Chief Medical Officer Officer |
5,651
-13.4%
25.02USD 141,363 |
5,651 -13.4% | 25.02 | USD 141,363 | |
| 2024-01-25 | 2024-01-24 | S Sale |
Chief Medical Officer Officer |
5,600
-11.7%
25.01USD 140,052 |
5,600 -11.7% | 25.01 | USD 140,052 | |
| 2024-01-25 | 2024-01-24 | S Sale |
Executive Vice Chair Executive Director |
29,956
-18.1%
24.98USD 748,250 |
29,956 -18.1% | 24.98 | USD 748,250 | |
| 2024-01-25 | 2024-01-23 | S Sale |
Chief Medical Officer Officer |
3,096
-7.8%
25.00USD 77,400 |
3,096 -7.8% | 25.00 | USD 77,400 | |
| 2024-01-25 | 2024-01-23 | S Sale |
Chief Medical Officer Officer |
2,039
-4.9%
25.00USD 50,975 |
2,039 -4.9% | 25.00 | USD 50,975 | |
| 2024-01-25 | 2024-01-23 | S Sale |
Executive Vice Chair Executive Director |
5,044
-3.0%
24.97USD 125,950 |
5,044 -3.0% | 24.97 | USD 125,950 | |
| 2024-01-24 | 2024-01-23 | S Sale |
SVP & Chief Commercial Officer Officer |
500
-1.3%
25.00USD 12,500 |
500 -1.3% | 25.00 | USD 12,500 | |
| 2024-01-24 | 2024-01-23 | S Sale |
SVP & Chief Commercial Officer Officer |
400
-1.0%
25.00USD 10,000 |
400 -1.0% | 25.00 | USD 10,000 | |
| 2024-01-24 | 2024-01-22 | S Sale |
SVP & Chief Commercial Officer Officer |
28,750
-43.1%
22.69USD 652,254 |
28,750 -43.1% | 22.69 | USD 652,254 | |
| 2024-01-24 | 2024-01-22 | S Sale |
SVP & Chief Commercial Officer Officer |
5,416
-7.5%
22.24USD 120,437 |
5,416 -7.5% | 22.24 | USD 120,437 | |
| 2024-01-16 | 2024-01-11 | S Sale | Non-Executive Director |
1,910,500
-95.0%
19.45USD 37,159,225 |
1,910,500 -95.0% | 19.45 | USD 37,159,225 | |
| 2024-01-16 | 2024-01-11 | S Sale | Non-Executive Director |
1,910,500
-95.0%
19.45USD 37,159,225 |
1,910,500 -95.0% | 19.45 | USD 37,159,225 | |
| 2024-01-11 | 2024-01-11 | B Purchase |
Cormorant Asset Management, LP Large shareholder |
750,000
+12.2%
19.75USD 14,812,500 |
750,000 +12.2% | 19.75 | USD 14,812,500 | |
| 2024-01-11 | 2024-01-09 | B Purchase |
Cormorant Asset Management, LP Large shareholder |
105,000
+1.7%
21.32USD 2,238,600 |
105,000 +1.7% | 21.32 | USD 2,238,600 | |
| 2024-01-10 | 2024-01-08 | S Sale |
Chief Medical Officer Officer |
22,913
-38.6%
21.13USD 484,124 |
22,913 -38.6% | 21.13 | USD 484,124 | |
| 2023-12-15 | 2023-12-13 | S Sale |
Chief Medical Officer Officer |
1,458
-5.4%
20.00USD 29,160 |
1,458 -5.4% | 20.00 | USD 29,160 | |
| 2023-12-12 | 2023-12-08 | B Purchase |
Cormorant Asset Management, LP Large shareholder |
588,235
+10.8%
17.00USD 9,999,995 |
588,235 +10.8% | 17.00 | USD 9,999,995 | |
| 2023-12-07 | 2023-12-06 | S Sale | Non-Executive Director |
266,242
-11.7%
18.41USD 4,901,515 |
266,242 -11.7% | 18.41 | USD 4,901,515 | |
| 2023-12-07 | 2023-12-06 | S Sale | Non-Executive Director |
266,242
-11.7%
18.41USD 4,901,515 |
266,242 -11.7% | 18.41 | USD 4,901,515 | |
| 2023-12-07 | 2023-12-05 | S Sale | Non-Executive Director |
733,758
-24.4%
19.91USD 14,609,122 |
733,758 -24.4% | 19.91 | USD 14,609,122 | |
| 2023-12-07 | 2023-12-05 | S Sale | Non-Executive Director |
733,758
-24.4%
19.91USD 14,609,122 |
733,758 -24.4% | 19.91 | USD 14,609,122 | |
| 2023-12-06 | 2023-12-04 | S Sale |
Executive Vice Chair Executive Director |
20,000
-10.5%
20.76USD 415,200 |
20,000 -10.5% | 20.76 | USD 415,200 | |
| 2023-12-06 | 2023-12-04 | B Purchase |
Cormorant Asset Management, LP Large shareholder |
8,260
+0.2%
34.49USD 284,887 |
8,260 +0.2% | 34.49 | USD 284,887 | |
| 2023-12-06 | 2023-12-04 | B Purchase |
Cormorant Asset Management, LP Large shareholder |
19,866
+0.4%
33.75USD 670,478 |
19,866 +0.4% | 33.75 | USD 670,478 | |
| 2023-12-06 | 2023-12-04 | B Purchase |
Cormorant Asset Management, LP Large shareholder |
41,824
+0.8%
33.08USD 1,383,538 |
41,824 +0.8% | 33.08 | USD 1,383,538 | |
| 2023-12-06 | 2023-12-04 | B Purchase |
Cormorant Asset Management, LP Large shareholder |
86,713
+1.6%
31.83USD 2,760,075 |
86,713 +1.6% | 31.83 | USD 2,760,075 | |
| 2023-12-06 | 2023-12-04 | B Purchase |
Cormorant Asset Management, LP Large shareholder |
15,582
+0.3%
30.74USD 478,991 |
15,582 +0.3% | 30.74 | USD 478,991 | |
| 2023-12-06 | 2023-12-04 | B Purchase |
Cormorant Asset Management, LP Large shareholder |
18,601
+0.4%
29.91USD 556,356 |
18,601 +0.4% | 29.91 | USD 556,356 | |
| 2023-12-06 | 2023-12-04 | B Purchase |
Cormorant Asset Management, LP Large shareholder |
8,168
+0.2%
28.78USD 235,075 |
8,168 +0.2% | 28.78 | USD 235,075 | |
| 2023-12-06 | 2023-12-04 | B Purchase |
Cormorant Asset Management, LP Large shareholder |
27,425
+0.5%
27.87USD 764,335 |
27,425 +0.5% | 27.87 | USD 764,335 | |
| 2023-12-06 | 2023-12-04 | B Purchase |
Cormorant Asset Management, LP Large shareholder |
53,109
+1.0%
26.73USD 1,419,604 |
53,109 +1.0% | 26.73 | USD 1,419,604 | |
| 2023-12-06 | 2023-12-04 | B Purchase |
Cormorant Asset Management, LP Large shareholder |
65,086
+1.3%
25.88USD 1,684,426 |
65,086 +1.3% | 25.88 | USD 1,684,426 | |
| 2023-12-06 | 2023-12-04 | B Purchase |
Cormorant Asset Management, LP Large shareholder |
39,899
+0.8%
24.87USD 992,288 |
39,899 +0.8% | 24.87 | USD 992,288 | |
| 2023-12-06 | 2023-12-04 | B Purchase |
Cormorant Asset Management, LP Large shareholder |
37,081
+0.7%
24.01USD 890,315 |
37,081 +0.7% | 24.01 | USD 890,315 | |
| 2023-12-06 | 2023-12-04 | B Purchase |
Cormorant Asset Management, LP Large shareholder |
28,090
+0.6%
22.80USD 640,452 |
28,090 +0.6% | 22.80 | USD 640,452 | |
| 2023-12-06 | 2023-12-04 | B Purchase |
Cormorant Asset Management, LP Large shareholder |
79,805
+1.6%
21.87USD 1,745,335 |
79,805 +1.6% | 21.87 | USD 1,745,335 | |
| 2023-12-06 | 2023-12-04 | B Purchase |
Cormorant Asset Management, LP Large shareholder |
122,625
+2.6%
20.62USD 2,528,528 |
122,625 +2.6% | 20.62 | USD 2,528,528 | |
| 2023-12-06 | 2023-12-04 | B Purchase |
Cormorant Asset Management, LP Large shareholder |
945,664
+24.5%
19.88USD 18,799,800 |
945,664 +24.5% | 19.88 | USD 18,799,800 | |
| 2023-12-06 | 2023-12-04 | B Purchase |
Cormorant Asset Management, LP Large shareholder |
321,259
+9.1%
18.80USD 6,039,669 |
321,259 +9.1% | 18.80 | USD 6,039,669 | |
| 2023-12-06 | 2023-12-04 | S Sale |
Chief Corp Dev.&Strat. Officer Officer |
45,000
-89.4%
22.00USD 990,000 |
45,000 -89.4% | 22.00 | USD 990,000 | |
| 2023-12-06 | 2023-12-04 | S Sale |
Chief Medical Officer Officer |
30,625
-54.4%
22.00USD 673,750 |
30,625 -54.4% | 22.00 | USD 673,750 | |
| 2023-09-06 | 2023-09-01 | S Sale |
See footnotes 1 and 3 Large shareholder |
20,000
-0.6%
9.90USD 197,982 |
20,000 -0.6% | 9.90 | USD 197,982 | |
| 2023-09-01 | 2023-08-31 | S Sale |
See footnotes 1 and 6 Large shareholder |
7,017
-0.2%
11.02USD 77,337 |
7,017 -0.2% | 11.02 | USD 77,337 | |
| 2023-09-01 | 2023-08-31 | S Sale |
See footnotes 1 and 6 Large shareholder |
71,478
-2.0%
10.17USD 726,724 |
71,478 -2.0% | 10.17 | USD 726,724 | |
| 2023-09-01 | 2023-08-30 | S Sale |
See footnotes 1 and 6 Large shareholder |
327
-0.0%
11.36USD 3,715 |
327 -0.0% | 11.36 | USD 3,715 | |
| 2023-09-01 | 2023-08-30 | S Sale |
See footnotes 1 and 6 Large shareholder |
60,649
-1.7%
10.92USD 662,433 |
60,649 -1.7% | 10.92 | USD 662,433 | |
| 2023-08-30 | 2023-08-29 | S Sale |
See footnotes 1 and 4 Large shareholder |
565
-0.0%
11.56USD 6,531 |
565 -0.0% | 11.56 | USD 6,531 | |
| 2023-08-30 | 2023-08-29 | S Sale |
See footnotes 1 and 4 Large shareholder |
87,289
-2.3%
10.74USD 937,693 |
87,289 -2.3% | 10.74 | USD 937,693 | |
| 2023-08-30 | 2023-08-28 | S Sale |
See footnotes 1 and 4 Large shareholder |
60,858
-1.6%
11.71USD 712,653 |
60,858 -1.6% | 11.71 | USD 712,653 | |
| 2023-08-28 | 2023-08-25 | S Sale |
See footnotes 1 and 2 Large shareholder |
54,656
-1.4%
11.19USD 611,349 |
54,656 -1.4% | 11.19 | USD 611,349 | |
| 2023-08-28 | 2023-08-25 | S Sale |
See footnotes 1 and 2 Large shareholder |
30,000
-0.8%
10.67USD 320,130 |
30,000 -0.8% | 10.67 | USD 320,130 | |
| 2023-08-28 | 2023-08-24 | S Sale |
See footnotes 1 and 2 Large shareholder |
139,280
-3.5%
14.62USD 2,036,093 |
139,280 -3.5% | 14.62 | USD 2,036,093 |